Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

Autor: Pietrina Cottu, Christelle Jouannaud, N. Esposito, L. Dima-Martinez, Alain Lortholary, Chahinez Benkanoun, Marc Espié, V. Pottier, J-P. Spano, H. Attar-Rabia, P. Rivera, L. Moreau, Dominique Spaeth, Joseph Gligorov, Xavier Pivot, Jean-Marc Extra

Publikováno v: European Journal of Cancer. 82:230-236

HannaH (NCT00950300) and PrefHer (NCT01401166) studies validated the subcutaneous (H-s.c.) formulation of trastuzumab as effective and safe as intravenous (H-i.v.) and highly preferred by patients in early breast cancer. The present randomised Metasp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9352f71fe18497b4ad772851059533bd
https://doi.org/10.1016/j.ejca.2017.05.009

A multi-center evaluation of clinical pathways cost and time using real-life data in 411 breast cancer patients treated with intravenous versus subcutaneous Trastuzumab

Autor: N. Bahmad, J.F. Tournamille, V. Priou, G. Lebozec, N. Perez-staub, C. bernard Marty, R. Alfonsi, M.A. Mouret-reynier, C. Blein, M.C. Borg, H. Attar-rabia, C. Pers-regouby, A. Jaffre, J. Forget, Z. El Islami

Publikováno v: European Journal of Cancer. 92:S106-S107

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6c1878abf07a7cbbf918aafe28b6215
https://doi.org/10.1016/s0959-8049(18)30544-6

Patient preference of trastuzumab administration (SC versus IV) in HER2-positive metastatic breast cancer: Results of the randomised Metaspher study

Autor: Joseph Gligorov, V. Pottier, J-P. Spano, H. Attar-Rabia, P. Rivera, L. Dima-Martinez, C. Benkamoun, Christelle Jouannaud, Alain Lortholary, L. Moreau, E. Marc, Xavier Pivot, J.-M. Extra, Dominique Spaeth, N. Esposito, PH Cottu

Publikováno v: Annals of Oncology. 27:vi85

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5040681ff00d38d3dc92aaed879801f6
https://doi.org/10.1093/annonc/mdw365.53

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.

Autor: Gréa T; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon1-CNRS, University of Lyon, Villeurbanne Cedex, 69622, France.; Université Claude Bernard Lyon 1, INSA Lyon, Jean Monnet University, CNRS, UMR 5223 Ingénierie des Matériaux Polymères (IMP), Villeurbanne Cedex, 69622, France., Jacquot G; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Nano-H, St Quentin Fallavier, 38070, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Durand A; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon1-CNRS, University of Lyon, Villeurbanne Cedex, 69622, France.; MexBrain, 13 avenue Albert Einstein, Villeurbanne, 69100, France., Mathieu C; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Gasser A; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Zhu C; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France.; Equipe de Synthèse Pour l'Analyse, Institut Pluridisciplinaire Hubert Curien (IPHC), UMR 7178 CNRS/University of Strasbourg, Strasbourg, Cedex 2 67087, France., Banerjee M; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France.; Equipe de Synthèse Pour l'Analyse, Institut Pluridisciplinaire Hubert Curien (IPHC), UMR 7178 CNRS/University of Strasbourg, Strasbourg, Cedex 2 67087, France., Hucteau E; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Biomedicine Research Centre of Strasbourg (CRBS), Mitochondria, oxidative stress, and muscular protection laboratory (UR 3072), Strasbourg, 67000, France., Mallard J; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Biomedicine Research Centre of Strasbourg (CRBS), Mitochondria, oxidative stress, and muscular protection laboratory (UR 3072), Strasbourg, 67000, France., Lopez Navarro P; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Popescu BV; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Thomas E; LAGEPP University Claude Bernard Lyon 1, CNRS UMR 5007, Villeurbanne Cedex, 69622, France., Kryza D; LAGEPP University Claude Bernard Lyon 1, CNRS UMR 5007, Villeurbanne Cedex, 69622, France.; Imthernat Plateform, Hospices Civils of Lyon, Lyon, 69002, France., Sidi-Boumedine J; LAGEPP University Claude Bernard Lyon 1, CNRS UMR 5007, Villeurbanne Cedex, 69622, France.; Imthernat Plateform, Hospices Civils of Lyon, Lyon, 69002, France., Ferrauto G; Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, 10124, Italy., Gianolio E; Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, 10124, Italy., Fleith G; Université de Strasbourg, CNRS, Institut Charles Sadron (UPR 22), 23 rue du Loess, 67034, Strasbourg Cedex 2, BP 84047, France., Combet J; Université de Strasbourg, CNRS, Institut Charles Sadron (UPR 22), 23 rue du Loess, 67034, Strasbourg Cedex 2, BP 84047, France., Brun S; Poly-Dtech, Strasbourg, 67100, France., Erb S; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France.; Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR 7178, University of Strasbourg, CNRS, Strasbourg, 67087, France.; Infrastructure Nationale de Protéomique ProFI - FR2048, Strasbourg, 67087, France., Cianferani S; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France.; Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR 7178, University of Strasbourg, CNRS, Strasbourg, 67087, France.; Infrastructure Nationale de Protéomique ProFI - FR2048, Strasbourg, 67087, France., Charbonnière LJ; Equipe de Synthèse Pour l'Analyse, Institut Pluridisciplinaire Hubert Curien (IPHC), UMR 7178 CNRS/University of Strasbourg, Strasbourg, Cedex 2 67087, France., Fellmann L; SILABE, Université of Strasbourg, fort Foch, Niederhausbergen, 67207, France., Mirjolet C; Radiation Oncology Department, Preclinical Radiation Therapy and Radiobiology Unit, Centre Georges-François Leclerc, Unicancer, Dijon, 21000, France.; TIReCS team, INSERM UMR 1231, Dijon, 21000, France., David L; Université Claude Bernard Lyon 1, INSA Lyon, Jean Monnet University, CNRS, UMR 5223 Ingénierie des Matériaux Polymères (IMP), Villeurbanne Cedex, 69622, France., Tillement O; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon1-CNRS, University of Lyon, Villeurbanne Cedex, 69622, France., Lux F; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon1-CNRS, University of Lyon, Villeurbanne Cedex, 69622, France.; University Institute of France (IUF), Paris, 75231, France., Harlepp S; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Pivot X; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France., Detappe A; Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, 67000, France.; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, 67000, France.; Equipe de Synthèse Pour l'Analyse, Institut Pluridisciplinaire Hubert Curien (IPHC), UMR 7178 CNRS/University of Strasbourg, Strasbourg, Cedex 2 67087, France.

Publikováno v: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Mar; Vol. 36 (13), pp. e2308738. Date of Electronic Publication: 2023 Dec 17.